Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jun;71(6):1779–1786. doi: 10.1172/JCI110933

HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.

P M Sondel, J A Hank, T Wendel, B Flynn, M J Bozdech
PMCID: PMC370383  PMID: 6223050

Abstract

Lymphocytes from a healthy HLA-identical bone marrow transplant donor were tested for their ability to destroy her brother's acute myelogenous leukemia blasts in vitro. Primary mixed lymphocyte culture (MLC) and cell-mediated lysis (CML) responses between the patient's remission (pretransplant) and donor's lymphocytes were negative. Stimulation of donor lymphocytes for 7 d in vitro with irradiated leukemia cells, leukemia cells plus allogeneic irradiated lymphocytes, or a pool of irradiated lymphocytes from 10 donors, did not activate any cytotoxic cells able to destroy the HLA identical leukemic blasts. Further culturing for 7 additional d in T cell growth factor (TCGF) generated lymphocytes that induced effective cytotoxicity against the leukemic blasts, but not against autologous lymphocytes. Effective killing against the leukemia was observed only in cultures initially stimulated with the irradiated leukemia cells. These cytotoxic cells were maintained in TCGF and mediated persistent killing against the leukemic target cells. They were also able to destroy lymphocytes from the patient's mother and father, but not from an unrelated cell donor. This suggested specific recognition of non-HLA antigens inherited by the patient, that were foreign to the HLA identical bone marrow donor. These lymphocytes were cloned by a limiting dilution technique and one clone maintained cytotoxicity to the AML blasts and the father's lymphocytes, but not lymphocytes from the mother or an HLA-identical donor. This cytotoxicity was inhibited by a monoclonal anti-HLA antibody. Thus, in vitro sensitization of this sibling's lymphocytes with AML blasts followed by TCGF expansion, and cloning, enabled the detection of HLA-restricted cytotoxic cells that recognize minor locus histocompatibility antigens. This immune recognition may be relevant to the "graft vs. leukemia" effect that has been observed in leukemic animals and patients following histocompatible hematopoietic transplants.

Full text

PDF
1779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., Bach M. L., Sondel P. M. Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature. 1976 Jan 29;259(5541):273–281. doi: 10.1038/259273a0. [DOI] [PubMed] [Google Scholar]
  2. Benacerraf B. Role of MHC gene products in immune regulation. Science. 1981 Jun 12;212(4500):1229–1238. doi: 10.1126/science.6165083. [DOI] [PubMed] [Google Scholar]
  3. Bevan M. J. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med. 1975 Dec 1;142(6):1349–1364. doi: 10.1084/jem.142.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bortin M. M., Truitt R. L., Rimm A. A., Bach F. H. Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature. 1979 Oct 11;281(5731):490–491. doi: 10.1038/281490a0. [DOI] [PubMed] [Google Scholar]
  5. Brodsky F. M., Parham P. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol. 1982 Jan;128(1):129–135. [PubMed] [Google Scholar]
  6. Cheever M. A., Greenberg P. D., Fefer A., Gillis S. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. J Exp Med. 1982 Apr 1;155(4):968–980. doi: 10.1084/jem.155.4.968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chess L., Bock G. N., Mardiney M. R., Jr Restoration of the reactivity of frozen stored human lymphocytes in the mixed lymphocyte reaction and in response to specific antigens. Transplantation. 1972 Dec;14(6):728–733. doi: 10.1097/00007890-197212000-00010. [DOI] [PubMed] [Google Scholar]
  8. Finke J. H., Scott J., Gillis S., Hilfiker M. L. Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2. J Immunol. 1983 Feb;130(2):763–767. [PubMed] [Google Scholar]
  9. Garman R. D., Fan D. P. Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes. J Immunol. 1983 Feb;130(2):756–762. [PubMed] [Google Scholar]
  10. Garovoy M. R., Franco V., Zschaeck D., Carpenter C. B., Strom T. B., Merrill J. P. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation. Lancet. 1973 Mar 17;1(7803):573–576. doi: 10.1016/s0140-6736(73)90717-4. [DOI] [PubMed] [Google Scholar]
  11. Goulmy E., Termijtelen A., Bradley B. A., van Rood J. J. Y-antigen killing by T cells of women is restricted by HLA. Nature. 1977 Apr 7;266(5602):544–545. doi: 10.1038/266544a0. [DOI] [PubMed] [Google Scholar]
  12. Goulmy E., van Leeuwen A., Blokland E., van Rood J. J., Biddison W. E. Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants. J Exp Med. 1982 May 1;155(5):1567–1572. doi: 10.1084/jem.155.5.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hank J. A., Inouye H., Guy L. A., Alter B. J., Bach F. H. Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer. J Supramol Struct. 1980;13(4):525–532. doi: 10.1002/jss.400130411. [DOI] [PubMed] [Google Scholar]
  14. Hank J. A., Sondel P. M. Soluble bacterial antigen induces specific helper and cytotoxic responses by human lymphocytes in vitro. J Immunol. 1982 Jun;128(6):2734–2738. [PubMed] [Google Scholar]
  15. Hayes C. E., Macphail S., Bach F. H. Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement-treated lymphocytes. J Exp Med. 1980 May 1;151(5):1305–1310. doi: 10.1084/jem.151.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hünig T. R., Bevan M. J. Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis. J Exp Med. 1982 Jan 1;155(1):111–125. doi: 10.1084/jem.155.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Inouye H., Hank J. A., Alter B. J., Bach F. H. TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol. 1980;12(2):149–154. doi: 10.1111/j.1365-3083.1980.tb00051.x. [DOI] [PubMed] [Google Scholar]
  18. Lee S. K., Oliver R. T. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. J Exp Med. 1978 Mar 1;147(3):912–922. doi: 10.1084/jem.147.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lotze M. T., Line B. R., Mathisen D. J., Rosenberg S. A. The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors. J Immunol. 1980 Oct;125(4):1487–1493. [PubMed] [Google Scholar]
  20. Lotze M. T., Strausser J. L., Rosenberg S. A. In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells. J Immunol. 1980 Jun;124(6):2972–2978. [PubMed] [Google Scholar]
  21. Macphail S., Yron I., Stutman O. Primary in vitro cytotoxic T cell response to non-major histocompatibility complex alloantigens in normal mice. J Exp Med. 1982 Aug 1;156(2):610–621. doi: 10.1084/jem.156.2.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McMichael A. J., Parham P., Brodsky F. M., Pilch J. R. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies. J Exp Med. 1980 Aug 1;152(2 Pt 2):195s–203s. [PubMed] [Google Scholar]
  23. Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976 Sep 10;193(4257):1007–1008. doi: 10.1126/science.181845. [DOI] [PubMed] [Google Scholar]
  24. Roopenian D. C., Widmer M. B., Orosz C. G., Bach F. H. Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. J Immunol. 1983 Feb;130(2):542–545. [PubMed] [Google Scholar]
  25. Slease R. B., Strong D. M., Gawith K. E., Bonnard G. D. Clinical effects of infusions into chimpanzees of primed autologous cultured T-cells. J Natl Cancer Inst. 1981 Aug;67(2):489–493. [PubMed] [Google Scholar]
  26. Smith K. A., Lachman L. B., Oppenheim J. J., Favata M. F. The functional relationship of the interleukins. J Exp Med. 1980 Jun 1;151(6):1551–1556. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sondel P. M., Bach F. H. Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen-specific inhibition of human cell-mediated lympholysis. J Exp Med. 1975 Dec 1;142(6):1339–1348. doi: 10.1084/jem.142.6.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sondel P. M., Bach F. H. Recognitive specificity of human cytotoxic T lymphocytes. II. The non-recognition of antigens controlled outside the major histocompatibility complex. Tissue Antigens. 1976 Mar;7(3):173–180. doi: 10.1111/j.1399-0039.1976.tb01048.x. [DOI] [PubMed] [Google Scholar]
  29. Sondel P. M., Borcherding W., Shahidi N. T., Ganick D. J., Schultz J. C., Hong R. Recategorizing childhood acute lymphoblastic leukemia with monoclonal antibodies to human T cells. Blood. 1981 Jun;57(6):1135–1137. [PubMed] [Google Scholar]
  30. Sondel P. M., Hank J. A. Alien-driven diversity and alien-selected escape: a rationale for allogeneic cancer immunotherapy. Transplant Proc. 1981 Dec;13(4):1915–1921. [PubMed] [Google Scholar]
  31. Sondel P. M., Jacobson M. W., Bach F. H. Pre-emption of human cell-mediated lympholysis by a suppressive mechanism activated in mixed lymphocyte cultures. J Exp Med. 1975 Dec 1;142(6):1606–1611. doi: 10.1084/jem.142.6.1606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sondel P. M., O'Brien C., Porter L., Schlossman S. F., Chess L. Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. J Immunol. 1976 Dec;117(6):2197–2203. [PubMed] [Google Scholar]
  33. Truitt R. L., Shih C. Y., Rimm A. A., Tempelis L. D., Bortin M. M. Alloimmunization and adoptive immunotherapy of leukemia. Transplant Proc. 1981 Dec;13(4):1910–1914. [PubMed] [Google Scholar]
  34. Weiden P. L., Flournoy N., Thomas E. D., Prentice R., Fefer A., Buckner C. D., Storb R. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med. 1979 May 10;300(19):1068–1073. doi: 10.1056/NEJM197905103001902. [DOI] [PubMed] [Google Scholar]
  35. Weiden P. L., Sullivan K. M., Flournoy N., Storb R., Thomas E. D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 1981 Jun 18;304(25):1529–1533. doi: 10.1056/NEJM198106183042507. [DOI] [PubMed] [Google Scholar]
  36. Weiss A., MacDonald H. R., Cerottini J. C., Brunner K. T. Inhibition of cytolytic T lymphocyte clones reactive with Moloney leukemia virus-associated antigens by monoclonal antibodies: a direct approach to the study of H-2 restriction. J Immunol. 1981 Feb;126(2):482–485. [PubMed] [Google Scholar]
  37. Yust I., Wunderlich J., Mann D. L., Rogentine G. N., Jr, Leventhal B., Yankee R., Graw R. Human lymphocyte-dependent antibody mediated cytotoxicity and direct lymphocyte cytotoxicity against non-HL-A antigens. Nature. 1974 May 17;249(454):263–265. doi: 10.1038/249263a0. [DOI] [PubMed] [Google Scholar]
  38. Zarling J. M., Bach F. H. Enhanced cytotoxicity of allosensitized T cells for autologous lymphoblastoid cell lines and human leukemia cells following propagation in T-cell growth factor. Transplant Proc. 1980 Mar;12(1):164–166. [PubMed] [Google Scholar]
  39. Zarling J. M., Raich P. C., McKeough M., Bach F. H. Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature. 1976 Aug 19;262(5570):691–693. doi: 10.1038/262691a0. [DOI] [PubMed] [Google Scholar]
  40. Zarling J. M., Robins H. I., Raich P. C., Bach F. H., Bach M. L. Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature. 1978 Jul 20;274(5668):269–271. doi: 10.1038/274269a0. [DOI] [PubMed] [Google Scholar]
  41. Zier K. S., Elkins W. L., Pierson G. R. Cytotoxic T lymphocyte lines (CTLL) against a human minor alloantigen. Immunogenetics. 1982;15(5):501–508. doi: 10.1007/BF00345909. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES